Reliq Health Technologies Inc V.RHT

Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a Canada-based global healthcare technology company that specializes in developing virtual care solutions. The Company's target markets include virtual care, long-term care and big data. iUGO Care, the Company's platform, is a software as a service solution that supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, remote therapeutic monitoring and wound care. Its behavioral health integration service supports patients with any mental, behavioral, or psychiatric health diagnoses by integrating mental health, psychiatric care, counseling, and addiction services with primary care.

TSXV:RHT - Post by User

Reliq Health Technologies Inc > Healthcare sector: Reliq (RHT) and Cipher (CPH)

<< Previous

Bullboard Posts

Next >>

Comment by stockfyon Feb 03, 2021 10:06am

272 Views

Post# 32457347

RE:Healthcare sector: Reliq (RHT) and Cipher (CPH)

Supreme, good luck to you too.

stockfy wrote:

I realize RHT's potential if RHT improves its balance sheet, but if you look for grossly undervalued healthcare companies with zero debt, revenue, profits and positive operating cash flow, check dirt-cheap Cipher Pharmaceuticals (CPH).

For instance, CPH produces several dermatological products including its excellent creams for acne (i.e. its well-known Epuris has 41% market share in Canada).

As linked below, CPH is debt-free, profitable and dirt-cheap currently trading just 1.3 times its 2020 EBITDA.

And the thing is that CPH has many levers to pull for revenue growth in 2021 because it has many promising drugs in the pipeline with very positive clinical trials to-date:

https://www.newswire.ca/news-releases/cipher-pharmaceuticals-reports-third-quarter-2020-financial-results-834044358.html